Announced Tue, 30 Jun · 15:53 IST
NCLAT interim order in Supha Pharmachem CIRP matter
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹0.31
prior close
₹0.32
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0—+0.0-3.1+0.0+3.2+6.5+9.7+9.7+0.0+6.5———
Up moveDown movePending
AI summary
Supha Pharmachem (formerly Remedium Lifecare) is undergoing CIRP. NCLAT declined to entertain Medec Infra's appeal challenging its exclusion from the Committee of Creditors as a related party, but granted interim protection until 29 June 2026: the CoC cannot vote on any resolution plan and no immovable property of the company can be sold. The main matter is listed before the Adjudicating Authority on 29 June 2026.
Likely market impact
CIRP process delayed; resolution plan voting and asset sales frozen until 29 June 2026 hearing. Continued uncertainty for shareholders.